Probucol

普罗布考

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameProbucol
Drug Alias Name普罗布可ProbucolumPanavirSinlestalLurselle +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsIschemic StrokeCognition DisordersHypercholesterolemia +[7] 
Global Approved IndicationsHypercholesterolemiaHyperlipidemias
Approved Indications in ChinaHypercholesterolemia
Original Approved Country/TerritoryUnited States
Original Approved Date1977/02/01
Country/TerritoryCanadaUnited StatesSouth Korea +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesFirst Affiliated Hospital Of Wannan Medical CollegeWuyi Cihang Pharmaceutical Co Ltd
Inactive CompaniesDouglas Mental Health University InstituteSanofi-Aventis U.S. LlcKorea Otsuka Pharmaceutical Co Ltd +[4] 
Active IndicationsIschemic StrokeHypercholesterolemiaIschemic Attack, Transient
Inactive IndicationsCognition DisordersHyperlipidemiasDiabetic Nephropathies +[4] 

Other Information

ATC CodeC10AX02
Related LinksWikipediaDrugBankKEGG